Paulson Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Paulson Wealth Management's BMY Position: Q2 2026 in Review
Paulson Wealth Management opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 3,777 shares worth $218K. The stake represents 0.05% of the portfolio and ranks #139 among its holdings. This is a return to the name: Paulson Wealth Management previously reported a position in BMY as recently as Q3 2023.
Paulson Wealth Management first reported a position in BMY in Q3 2023 and has held it in 2 quarters since. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Paulson Wealth Management held 3,777 shares of Bristol-Myers Squibb worth $218K as of Q2 2026.
- Bristol-Myers Squibb was a new Paulson Wealth Management position in Q2 2026.
- Bristol-Myers Squibb made up 0.05% of Paulson Wealth Management's portfolio in Q2 2026, its #139 holding.
- Paulson Wealth Management first reported a position in Bristol-Myers Squibb in Q3 2023 and has held it in 2 quarters since.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Paulson Wealth Management's 13F filing for Q2 2026, filed 4 Aug 2026.